Copaxone and Asa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Copaxone (glatiramer acetate) and Asa (aspirin). Common drug interactions include pain among females and gait disturbance among males.

The phase IV clinical study analyzes what interactions people have when they take Copaxone and Asa. It is created by eHealthMe based on reports of 75 people who take the same drugs from the FDA, and is updated regularly.

What is Copaxone?

Copaxone has active ingredients of glatiramer acetate. It is often used in multiple sclerosis. eHealthMe is studying from 56,931 Copaxone users. Check the latest studies of Copaxone.

What is Asa?

Asa has active ingredients of aspirin. It is often used in blood clots. eHealthMe is studying from 32,557 Asa users. Check the latest studies of Asa.

On Aug, 10, 2026

75 people who take Copaxone and Asa together, and have interactions are studied.

What are the common drug interactions of Copaxone and Asa, by gender? *:

female:

Pain
Pruritus (severe itching of the skin)
Suicidal ideation
Suicide attempt
Tremor (trembling or shaking movements in one or more parts of your body)
Vomiting
Dyskinesia (abnormality or impairment of voluntary movement)
Abasia (inability to walk)
Agitation (state of anxiety or nervous excitement)
Alopecia (absence of hair from areas of the body)

male:

Gait disturbance
Adverse event
Anaemia (lack of blood)
Atrioventricular block first degree (heart block first degree)
Balance disorder
Bladder disorder
Blood pressure decreased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)

What are the common drug interactions of Copaxone and Asa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Depression
Injection site reaction
Fatigue (feeling of tiredness)
Suicidal ideation
Suicide attempt
Adverse event
Anxiety
Balance disorder
Contusion (a type of hematoma of tissue in which capillaries)
Dyspnoea (difficult or laboured respiration)

50-59:

Bladder disorder
Blindness
Blood pressure decreased
Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)
Carotid artery occlusion (artery blockage)
Chest pain
Chills (felling of cold)
Cholecystitis (infection of gallbladder)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)

60+:

Fatigue (feeling of tiredness)
Headache (pain in head)
Swelling
Tooth infection
Weight increased
Feeling cold
Abdominal pain upper
Back pain
Blood creatinine increased
Cholecystitis (infection of gallbladder)

What are the existing conditions these people have? *

Gait Disturbance: 6 people, 8.00%
Type 2 Diabetes: 5 people, 6.67%
High Blood Cholesterol: 5 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Copaxone and Asa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously